Stent, Urethral, Prostatic, Semi-Permanent
NZC is the FDA product code for Stent, Urethral, Prostatic, Semi-Permanent, a class III device type. FDA's definition for this code reads: "Approximately 3 cm tube placed in the prostatic urethra for short term use to drain urine. The device includes a retention mechanism that anchors in the bladder neck to hold it in place and a release mechanism that exits the penis. For short term use in men with partial of full prostatic urethral obstruction or the...". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- NZC
- Device name
- Stent, Urethral, Prostatic, Semi-Permanent
- FDA definition
- Approximately 3 cm tube placed in the prostatic urethra for short term use to drain urine. The device includes a retention mechanism that anchors in the bladder neck to hold it in place and a release mechanism that exits the penis. For short term use in men with partial of full prostatic urethral obstruction or the prevention of prostatic urethral obstruction post surgery or other prostatic treatment.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
